Astex Announces Drug Discovery Collaboration with the Institute of Cancer Research and Cancer Research Technology CAMBRIDGE, U.K., March 20, 2003 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced an exclusive research collaboration and licence agreement with the...

ViroPharma Announces the Initiation of Phase 1 Hepatitis C Trials and Updates its Product Pipeline and Convertible Notes EXTON, Pa., Jan. 3, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that, together with Wyeth, it has initiated phase 1 human clinical trials with HCV 371, the lead compound...

Akzo Nobel and Organon Considering Next Moves Following Adverse Summary Judgement Ruling in Remeron Lawsuit Against Generics ARNHEM, The Netherlands and WEST ORANGE, N.J., Dec. 19, 2002 (PRIMEZONE) -- Akzo Nobel (Nasdaq:AKZOY) and Organon Inc. confirm that the U.S. Federal District Court in Newark, NJ, has granted summary...

Medivir and Paradigm Enter Alliance HUDDINGE, Sweden, Dec. 13, 2002 (PRIMEZONE) -- Medivir and Paradigm Therapeutics Ltd (Cambridge, U.K.) have entered a broad-based, 3-year research collaboration to identify novel protease drug...

Pharmexa Announces that GlaxoSmithKline has Exclusive Option on HER-2 Protein Breast Cancer Project HORSHOLM, Denmark, April 12, 2002 (PRIMEZONE) -- In June 2001 Pharmexa announced that it had in-licensed a vector-cell production system from GlaxoSmithKline (NYSE:GSK) for use in Pharmexa's...